Free Trial

Sunshine Biopharma (SBFM) Insider Trading & Ownership

Sunshine Biopharma logo
$2.78 -0.02 (-0.71%)
(As of 12/20/2024 05:45 PM ET)

Sunshine Biopharma (NASDAQ:SBFM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.10%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$10,000.00
Number Of
Insiders Selling
(Last 12 Months)
0
Get SBFM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Sunshine Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SBFM Insider Buying and Selling by Quarter

Sunshine Biopharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/4/2024Steve N SlilatyCEOBuy1,000$10.00$10,000.00  
(Data available from 1/1/2013 forward)

SBFM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Sunshine Biopharma includes Camille Sebaaly, and Steve N Slilaty. Learn more on insiders at SBFM.

0.10% of Sunshine Biopharma stock is owned by insiders. Learn more on SBFM's insider holdings.

The following insider purchased SBFM shares in the last 24 months: Steve N Slilaty ($10,000.00).

Insiders have purchased a total of 1,000 SBFM shares in the last 24 months for a total of $10,000.00 bought.

Sunshine Biopharma Key Executives

  • Dr. Steve N. Slilaty Ph.D. (Age 72)
    CEO, President & Chairman
    Compensation: $640k
  • Mr. Camille Sebaaly (Age 65)
    CFO & Secretary
    Compensation: $695k
  • Dr. Abderrazzak Merzouki (Age 60)
    Chief Science Officer & Director
    Compensation: $340k
  • Mr. Marc Beaudoin (Age 57)
    Chief Operating Officer
  • Mr. Malek Chamoun (Age 39)
    Chief Development Officer
  • Mr. Robert G. Ferreira (Age 62)
    President of Sunshine Bio Investments Inc


This page (NASDAQ:SBFM) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners